IRS Says Mylan Can't Deduct $50M Patent Litigation Costs
By David Hansen · May 29, 2019, 5:44 PM EDT
Pharmaceutical giant Mylan Inc. should not win a $50 million tax deduction for patent litigation costs because those expenses were part of the government approval process for generic drugs, the IRS...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login